Close Menu

And Now a Lawsuit

The Economist takes a look at the Anil Potti misconduct case at Duke University — Potti, Joseph Nevins, and colleagues published reports saying that they could predict lung cancer progression based on gene expression levels determined using microarrays. Questions began to arise about the science as well as about some claims Potti made on various documents. This led to a number of papers being retracted, clinical trials being halted, and investigations being started. Potti resigned from his position at Duke.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.